Ipsen S.A. (IPSEY)
OTCMKTS
· Delayed Price · Currency is USD
28.33
-0.57 (-1.97%)
Feb 21, 2025, 3:19 PM EST
Ipsen Employees
Ipsen had 5,325 employees as of December 31, 2023. The number of employees increased by 253 or 4.99% compared to the previous year.
Employees
5,325
Change (1Y)
253
Growth (1Y)
4.99%
Revenue / Employee
$694,966
Profits / Employee
$67,251
Market Cap
9.48B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Ipsen News
- 9 days ago - Ipsen S.A. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 9 days ago - Ipsen S.A. (IPSEY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Ipsen S.A. Non-GAAP EPS of €10.27, revenue of €3.4B; initiates FY25 outlook - Seeking Alpha
- 3 months ago - Genfit Balances Ipsen Partnership With High-Risk Pipeline Ambitions - Seeking Alpha
- 4 months ago - Ipsen S.A. reports Q3 results; raises FY24 guidance - Seeking Alpha
- 5 months ago - Eton Pharmaceuticals to buy Increlex product from Ipsen - Seeking Alpha
- 5 months ago - Ipsen's Kayfanda® (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare liver disease - Benzinga
- 5 months ago - Ipsen's Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade - Benzinga